XML 33 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2018
Equity [Abstract]  
Schedule of Common Stock Reserved for Future Issuance
Shares of common stock reserved for future issuance related to outstanding equity awards, common stock warrants, and employee equity incentive plans were as follows (in thousands):
 
 
June 30, 2018
Stock options outstanding
 
3,333

Restricted stock units outstanding
 
2,705

Shares available for future grant under 2014 Plan
 
8,666

Shares available for future issuance under ESPP
 
1,801

Common stock warrants outstanding
 
13

Total shares of common stock reserved
 
16,518

 
 
 
Schedule of Stock Option Activity
A summary of the Company’s stock option activity during the six months ended June 30, 2018 is as follows (in thousands, except years and per share data):
 
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life
(Years)
 
Aggregate
Intrinsic
Value
Outstanding as of December 31, 2017
 
4,047

 
$
8.00

 
 
 
 
Options granted (weighted average grant date fair value of $14.14 per share)
 
268

 
30.37

 
 
 
 
Options exercised
 
(974
)
 
5.93

 
 
 
 
Options forfeited or expired
 
(8
)
 
4.68

 
 
 
 
Outstanding as of June 30, 2018
 
3,333

 
$
10.41

 
6.4
 
$
80,524

 
 
 
 
 
 
 
 
 
Schedule of RSU Activity
A summary of the Company’s restricted stock unit (“RSU”) activity during the six months ended June 30, 2018 is as follows (in thousands, except per share data):     
 
 
Number of Shares
 
Weighted Average Grant Date Fair Value Per Share
Outstanding as of December 31, 2017
 
2,033

 
$
12.81

RSUs granted
 
1,285

 
30.51

RSUs vested and released
 
(534
)
 
12.25

RSUs forfeited
 
(79
)
 
17.64

Outstanding as of June 30, 2018
 
2,705

 
$
21.18

 
 
 
 
 
Schedule of Stock-based Compensation Expense
Stock-based compensation expenses were as follows (in thousands):
 
 
Three Months Ended
 
Six Months Ended
 
 
June 30, 2018
 
June 30, 2017
 
June 30, 2018
 
June 30, 2017
Cost of revenue
 
$
853

 
$
575

 
$
1,531

 
$
1,009

Research and development
 
1,064

 
801

 
1,941

 
1,438

Sales and marketing
 
1,585

 
1,224

 
2,947

 
2,152

General and administrative
 
3,295

 
1,254

 
5,703

 
2,384

Total stock-based compensation
 
$
6,797

 
$
3,854

 
$
12,122

 
$
6,983

 
 
 
 
 
 
 
 
 
Schedule of Unrecognized Compensation Expense
As of June 30, 2018, unrecognized stock-based compensation expenses by award type and their expected weighted-average recognition periods are summarized in the following table (in thousands, except years).
 
 
Stock Option
 
RSU
 
ESPP
Unrecognized stock-based compensation expense
 
$
11,366

 
$
56,023

 
$
708

Weighted-average amortization period
 
2.6 years

 
3.0 years

 
0.4 years

Schedule of Valuation Assumptions, Stock Option
The weighted-average assumptions used to value stock options granted during the periods presented were as follows:
Stock Options
 
Three Months Ended
 
Six Months Ended
 
 
June 30, 2018
 
June 30, 2017
 
June 30, 2018
 
June 30, 2017
Expected term (years)
 
6.1

 
6.1

 
6.0
 
6.2
Volatility
 
44
%
 
49
%
 
45%
 
49%
Risk-free interest rate
 
2.7
%
 
2.0
%
 
2.7%
 
2.0%
Dividend yield (1)
 

 

 
 
 
 
 
 
 
 
 
 
 
(1)
The Company has not paid, and does not anticipate paying, cash dividends on its shares of common stock. Accordingly, the expected dividend yield is zero.